Prometheus Biosciences Inc Shares Close the Week 21.3% Lower - Weekly Wrap
The company saw its shares close the week 21.3% lower than last week, with trading volume higher than its 30 day average.
Nov 26, 2021 by Kwhen Finance Editors
Prometheus Biosciences Inc (RXDX) shares closed this week 21.3% lower than it did at the end of last week. The stock is currently up 19.8% year-to-date, up 19.8% over the past 12 months, and up 19.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%.
Trading Activity
- Shares traded as high as $39.98 and as low as $26.99 this week.
- Trading volume this week was 29.7% lower than the 10-day average and 29.5% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Prometheus Biosciences Inc | 3.8 | 19.8 | 19.8 | ||
| Dow Jones Industrial Average | -2.5 | 18.8 | 21.9 | -4.0 | 20.9 |
| S&P 500 Index | -2.2 | 26.8 | 31.3 | -2.3 | 30.6 |
| Technology Industry | 7.8 | -63.9 | -70.7 | -69.8 | 12.5 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -228.1%
- The company's stock price performance over the past 12 months beats the peer average by -188.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Prometheus Biosciences Inc | RXDX | 0 | 19.8 | 19.8 | ||
| Peer Avg | N/A | 56.9 | -15.5 | -22.4 | ||
| Agenus Inc | AGEN | 227.8 | 5.0 | -4.8 | ||
| Akebia Therapeutics Inc. | AKBA | 0 | -0.4 | -15.5 | ||
| Epizyme Inc | EPZM | 0 | -66.7 | -69.5 | ||
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: